Article Information
History
- April 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Roderick C Slieker, PhD1,2,*,
- Louise A Donnelly, PhD3,*,
- Livia Lopez-Noriega, PhD4,
- Hermine Muniangi-Muhitu4,
- Elina Akalestou, PhD4,
- Mahsa Sheikh4,
- Eleni Georgiadou, PhD4,
- Giuseppe N. Giordano, PhD5,
- Mikael Åkerlund, PhD5,
- Emma Ahlqvist, PhD5,
- Ashfaq Ali, PhD6,
- Marko Barovic, MSc7,
- Gerard A Bouland, MSc2,
- Frédéric Burdet, MSc8,
- Mickaël Canouil, PhD9,
- Iulian Dragan, MSc8,
- Petra JM Elders, PhD10,
- Celine Fernandez, PhD5,
- Andreas Festa, MD11,12,
- Hugo Fitipaldi, MSc5,
- Phillippe Froguel9,13,
- Valborg Gudmundsdottir, PhD14,15,
- Vilmundur Gudnason, MD, PhD14,15,
- Mathias J. Gerl, PhD16,
- Amber A van der Heijden, PhD10,
- Lori L Jennings, PhD17,
- Michael K. Hansen, PhD18,
- Min Kim, PhD6,19,
- Isabelle Leclerc, MD PhD4,
- Christian Klose, PhD16,
- Dmitry Kuznetsov, PhD8,
- Dina Mansour Aly, MSc5,
- Florence Mehl, PhD8,
- Diana Marek, PhD8,
- Prof Olle Melander, PhD5,
- Anne Niknejad, MSc8,
- Filip Ottosson, MSc5,
- Imre Pavo, MD11,
- Alexander Efanov, PhD20,
- Kevin Duffin20,
- Timothy J. Pullen, PhD4,21,
- Prof Kai Simons, PhD16,
- Prof. Michele Solimena, PhD7,22,
- Tommi Suvitaival, PhD6,
- Asger Wretlind, MSc6,
- Prof Peter Rossing, MD6,23,
- Prof Valeriya Lyssenko, PhD24,25,
- Cristina Legido Quigley, PhD6,19,
- Prof Leif Groop, PhD5,26,
- Prof Bernard Thorens, PhD27,
- Prof Paul W Franks, PhD5,28,
- Mark Ibberson, PhD7,
- Prof Joline WJ Beulens, PhD1,29,
- Leen M ’t Hart, PhD1,2,30,*,†,
- Prof Ewan R Pearson, MD3,*,†† and
- Prof Guy A Rutter, PhD4,31,*,†††
- 1Department of Epidemiology and Data Science, Amsterdam Public Health Institute, Amsterdam Cardiovascular Sciences, Amsterdam UMC, location VUMC, Amsterdam, the Netherlands
- 2Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, the Netherlands
- 3Population Health & Genomics, School of Medicine, University of Dundee, Dundee, UK
- 4Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, U.K.
- 5Genetic and Molecular Epidemiology Unit, Lund University Diabetes Centre, Department of Clinical Sciences, CRC, Lund University, SUS, Malmö, Sweden
- 6Steno Diabetes Center Copenhagen, Gentofte, Denmark
- 7Paul Langerhans Institute Dresden (PLID) of the Helmholtz Center Munich at the University Hospital Carl Gustav Carus and Medical Faculty, Dresden, Germany
- 8Vital-IT Group, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland
- 9INSERM U1283, CNRS UMR 8199, European Genomic Institute for Diabetes (EGID), Institut Pasteur de Lille, University of Lille, Lille University Hospital, Lille, F-59000, France
- 10Department of General Practice and Elderly Care Medicine, Amsterdam Public Health Research Institute, Amsterdam UMC–location VUmc, Amsterdam, the Netherlands
- 11Eli Lilly Regional Operations GmbH, Vienna, Austria
- 121st Medical Department, LK Stockerau, Niederösterreich, Austria.
- 13Division of Systems Biology, Department of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK
- 14Faculty of Medicine, University of Iceland, Reykjavik, Iceland
- 15Icelandic Heart Association, Kopavogur, Iceland
- 16Lipotype GmbH Dresden Germany
- 17Novartis Institutes for Biomedical Research, Cambridge, MA 02139, USA
- 18Cardiovascular and Metabolic Disease Research, Janssen Research & Development, Spring House, Pennsylvania, U.S.A.
- 19Institute of Pharmaceutical Science, Faculty of Life Sciences and Medicines, King’s College London, London, United Kingdom
- 20Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, United States
- 21Department of Diabetes, Guy’s Campus King’s College London, U.K.
- 22Molecular Diabetology, University Hospital and Medical Faculty Carl Gustav Carus, TU Dresden, Dresden, Germany
- 23Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
- 24Department of Clinical Science, Center for Diabetes Research, University of Bergen, Bergen, Norway
- 25Genomics, Diabetes and Endocrinology Unit, Department of Clinical Sciences Malmö, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden
- 26Finnish Institute of Molecular Medicine, Helsinki University, Helsinki, Finland
- 27Center for Integrative Genomics, University of Lausanne, CH-1015, Lausanne, Switzerland
- 28Department of Nutrition, Harvard School of Public Health, Boston, MA, USA
- 29Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands
- 30Department of Biomedical Data Sciences, Section Molecular Epidemiology, Leiden University Medical Center, Leiden, the Netherlands
- 31Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore
- ↵†Corresponding authors Leen ‘t Hart, PhD Einthovenweg 20 2333ZC Leiden The Netherlands Telephone: +31 71 5269796 E-mail: lmthart{at}lumc.nl
- ↵††Prof Ewan Pearson, MD Ninewells Hospital Dundee DD1 9SY United Kingdom Telephone: +44 1382 383387 E-mail: E.Z.Pearson{at}dundee.ac.uk
- ↵†††Prof Guy A Rutter, PhD Section of Cell Biology and Functional Genomics, Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, Hammersmith Hospital Campus Du Cane Road, London, W12 0NN, U.K
↵* Contributed equally
Posted April 24, 2021.
Novel biomarkers for glycaemic deterioration in type 2 diabetes: an IMI RHAPSODY study
